ClearPoint Neuro Return on Tangible Equity 2010-2025 | CLPT
Current and historical return on tangible equity values for ClearPoint Neuro (CLPT) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| ClearPoint Neuro Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.02B | $0.02B | -75.47% |
| 2024-12-31 | $-0.02B | $0.03B | -60.00% |
| 2024-09-30 | $-0.02B | $0.03B | -62.07% |
| 2024-06-30 | $-0.02B | $0.03B | -64.86% |
| 2024-03-31 | $-0.02B | $0.03B | -79.25% |
| 2023-12-31 | $-0.02B | $0.02B | -88.46% |
| 2023-09-30 | $-0.02B | $0.02B | -73.95% |
| 2023-06-30 | $-0.02B | $0.03B | -62.69% |
| 2023-03-31 | $-0.02B | $0.03B | -48.32% |
| 2022-12-31 | $-0.02B | $0.04B | -39.51% |
| 2022-09-30 | $-0.02B | $0.04B | -36.78% |
| 2022-06-30 | $-0.02B | $0.04B | -35.75% |
| 2022-03-31 | $-0.02B | $0.05B | -34.78% |
| 2021-12-31 | $-0.02B | $0.05B | -32.97% |
| 2021-09-30 | $-0.01B | $0.04B | -38.24% |
| 2021-06-30 | $-0.01B | $0.05B | -43.48% |
| 2021-03-31 | $-0.01B | $0.04B | -69.57% |
| 2020-12-31 | $-0.01B | $0.00B | -560.00% |
| 2020-09-30 | $-0.01B | $0.00B | -400.00% |
| 2020-06-30 | $-0.01B | $0.00B | -215.38% |
| 2020-03-31 | $-0.01B | $0.00B | -155.56% |
| 2019-12-31 | $-0.01B | $0.00B | -150.00% |
| 2019-09-30 | $-0.01B | $0.01B | -153.85% |
| 2019-06-30 | $-0.01B | $0.01B | -222.22% |
| 2019-03-31 | $-0.01B | $0.00B | -333.33% |
| 2018-12-31 | $-0.01B | $0.00B | -240.00% |
| 2018-09-30 | $-0.01B | $0.00B | -200.00% |
| 2018-06-30 | $-0.01B | $0.00B | -155.56% |
| 2018-03-31 | $-0.01B | $0.00B | -121.74% |
| 2017-12-31 | $-0.01B | $0.01B | -175.00% |
| 2017-09-30 | $-0.01B | $0.01B | -311.11% |
| 2017-06-30 | $-0.01B | $0.01B | -1200.00% |
| 2017-03-31 | $-0.01B | $0.00B | 360.00% |
| 2016-12-31 | $-0.01B | $0.00B | 300.00% |
| 2016-09-30 | $-0.01B | $0.00B | 246.15% |
| 2016-06-30 | $-0.01B | $-0.01B | 100.00% |
| 2016-03-31 | $-0.01B | $-0.01B | 109.09% |
| 2015-12-31 | $-0.01B | $0.00B | 145.45% |
| 2015-09-30 | $-0.01B | $-0.01B | 180.00% |
| 2015-06-30 | $-0.01B | $-0.01B | 236.36% |
| 2015-03-31 | $-0.01B | $-0.01B | 240.00% |
| 2014-12-31 | $-0.01B | $0.00B | 105.26% |
| 2014-09-30 | $-0.01B | $-0.01B | 76.92% |
| 2014-06-30 | $0.00B | $-0.01B | 66.67% |
| 2014-03-31 | $0.00B | $0.00B | 52.17% |
| 2013-12-31 | $-0.01B | $-0.01B | 127.27% |
| 2013-09-30 | $0.00B | $-0.01B | 69.57% |
| 2013-06-30 | $0.00B | $0.00B | 69.57% |
| 2013-03-31 | $0.00B | $0.00B | 51.61% |
| 2012-12-31 | $-0.01B | $-0.01B | 58.54% |
| 2012-09-30 | $-0.01B | $-0.01B | 66.67% |
| 2012-06-30 | $-0.01B | $-0.01B | 68.09% |
| 2012-03-31 | $-0.01B | $-0.01B | 102.86% |
| 2011-12-31 | $-0.01B | $-0.02B | 145.45% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.314B | $0.031B |
| ClearPoint Neuro Inc. provides neurosurgery platform which includes hardware, software, clinical case and market development services for gene therapy cases principally in the United States and Europe. ClearPoint Neuro Inc., formerly known as MRI Interventions Inc., is based in Irvine, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $180.563B | 21.85 |
| Intuitive Surgical (ISRG) | United States | $177.754B | 73.68 |
| Edwards Lifesciences (EW) | United States | $46.928B | 31.13 |
| IDEXX Laboratories (IDXX) | United States | $45.454B | 52.24 |
| Alcon (ALC) | Switzerland | $45.309B | 30.62 |
| DexCom (DXCM) | United States | $34.894B | 53.93 |
| IQVIA Holdings (IQV) | United States | $33.859B | 19.13 |
| Mettler-Toledo (MTD) | United States | $26.269B | 31.24 |
| STERIS (STE) | Ireland | $22.671B | 24.97 |
| Waters (WAT) | United States | $18.028B | 25.44 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.531B | 0.00 |
| Hologic (HOLX) | United States | $14.819B | 16.10 |
| Sysmex ADR (SSMXY) | Japan | $10.682B | 30.30 |
| Penumbra (PEN) | United States | $9.027B | 70.85 |
| Masimo (MASI) | United States | $8.926B | 32.92 |
| Globus Medical (GMED) | United States | $7.375B | 17.57 |
| Glaukos (GKOS) | United States | $5.388B | 0.00 |
| Teleflex (TFX) | United States | $5.179B | 8.55 |
| Integer Holdings (ITGR) | United States | $3.786B | 18.97 |
| TransMedics (TMDX) | United States | $3.657B | 79.50 |
| PROCEPT BioRobotics (PRCT) | United States | $3.083B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.381B | 14.18 |
| Nihon Kohden (NHNKY) | Japan | $2.144B | 24.59 |
| Elekta AB (EKTAY) | Sweden | $1.991B | 17.90 |
| Veracyte (VCYT) | United States | $1.977B | 27.75 |
| Alphatec Holdings (ATEC) | United States | $1.582B | 0.00 |
| Artivion (AORT) | United States | $1.341B | 125.60 |
| OPKO Health (OPK) | United States | $1.086B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.058B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.019B | 5.42 |
| Pulse Biosciences (PLSE) | United States | $1.004B | 0.00 |
| SiBone (SIBN) | United States | $0.735B | 0.00 |
| IRadimed (IRMD) | United States | $0.716B | 36.33 |
| Beta Bionics (BBNX) | United States | $0.643B | 0.00 |
| AxoGen (AXGN) | United States | $0.609B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.555B | 8.64 |
| OrthoPediatrics (KIDS) | United States | $0.553B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.525B | 11.30 |
| Pacific Biosciences Of California (PACB) | United States | $0.462B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.442B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.416B | 9.67 |
| Delcath Systems (DCTH) | United States | $0.397B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.375B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.358B | 0.00 |
| RxSight (RXST) | United States | $0.324B | 0.00 |
| Neuronetics (STIM) | United States | $0.297B | 0.00 |
| NeuroPace (NPCE) | United States | $0.295B | 0.00 |
| 908 Devices (MASS) | United States | $0.266B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.245B | 14.86 |
| CVRx (CVRX) | United States | $0.217B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.203B | 0.00 |
| Inogen (INGN) | United States | $0.183B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.180B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.179B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.131B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.120B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.117B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.108B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.108B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.091B | 55.10 |
| EnVVeno Medical (NVNO) | United States | $0.087B | 0.00 |
| Hyperfine (HYPR) | United States | $0.084B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.067B | 0.00 |
| Spectral AI (MDAI) | United States | $0.066B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.053B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.053B | 21.44 |
| EDAP TMS S.A (EDAP) | France | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.018B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.013B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.10 |